POLE and cancer: In addition, other somatic point mutations in the polymerase domain of PolE (R567C, K593C, S595P, E611K, and L621F) and a deletion frameshift in the middle region of the PolE gene (V1446fs *3) are possible pathogenic factors in cancer [20,21].